The International Society of Endovascular Specialists (ISEVS) is dedicated to enhancing global research, education and clinical expertise in the treatment of one of the world’s number one killers – vascular disease. Using innovative technologies and interventional techniques ISEVS strives to improve patient care throughout the world.
About ISEVS
International Society of Endovascular Specialists
About ISEVS Indian Chapter
The ISEVS Indian Chapter was inaugurated during the 8th Asia Pacific Vascular Intervention Course / Fellows Course on 18th June, 2016 at the Taj Palace, New Delhi, India, in the presence of Prof Clifford Buckley and Ms Shirley Buckley. It was inaugurated in the traditional Indian way with lamp lighting by Prof Buckley, Ms Buckley, Prof Amal Banerjee, Prof N N Khanna and Prof Vinay Krishna.
Dr. (Prof) N N Khanna was appointed the President of the ISEVS Indian Chapter.
S. No. |
Name |
Designation |
| 1. | Dr N N Khanna | President |
| 2. | Dr Vinay Krishna | Secretary |
| 3. | Dr Edafe Emmanuel | Member |
| 4. | Dr Neeraj Prakash | Member |
| 5. | Dr Rajat Aggarwal | Member |
| 6. | Dr Rini Pramesti | Member |
| 7. | Dr Suparna Rao | Member |
| 8. | Dr B C Sathyanarayan | Member |
| 9. | Dr Ezhilan | Member |
| 10. | Dr M V Reddy | Member |
| 11. | Dr Monica Kher | Member |
| 12. | Dr Obiora Ajuluchukwu | Member |
| 13. | Dr P K Asokan | Member |
| 14. | Dr Peter Dodo Yakubu | Member |
| 15. | Dr Pramod Dhar | Member |
| 16. | Dr Saravanan | Member |
| 17. | Dr Shiba Chhabra | Member |
Vision Statement
- Encouraging multi-disciplinary communication among endovascular treatment specialists including vascular surgeons, interventional cardiologists, radiologists and other medical and surgical specialists;
- Utilizing varied educational formats to stimulate research and training including research seminars, symposia, Internet communication vehicles and professional publications; and,
- Creating interactions with other medical and scientific societies, healthcare agencies, payors and industry management to provide optimal cost-effective solutions to vascular disease syndromes.